Senior insider sale
Chief Operating Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$19.92M
260.77K shares
What this filing means
MONIA BRETT P plans to sell 260.77K shares of IONIS PHARMACEUTICALS INC valued at approximately $19.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/13/2026ACC: 0001972481-26-000157
Officer· Chief Operating Officer
Since Jul 2018
260.77K
Shares to sell
$19.92M
Approx. market value
100K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock Options
Equity Compensation
1/3/2022
50KStock Options
Equity Compensation
1/4/2021
50KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2022 | Stock Options Equity Compensation | 50K | — |
1/4/2021 | Stock Options Equity Compensation | 50K | — |
| Total | 100K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
34.10K
Market value
$2.59M
3/10/2026
—Completed
Units to sell
126.67K
Market value
$9.53M
3/9/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
100K
Market value
$7.80M
5/13/2026
Total
Units
260.77K
Value
$19.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 34.10K | $2.59M | — | Completed |
3/9/2026 | 126.67K | $9.53M | — | Completed |
| Planned — Approximate Date | ||||
5/13/2026 | 100K | $7.80M | Nasdaq | Planned |
| Total | 260.77K | $19.92M | ||